EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

FBXO9 mediated the ubiquitination and degradation of YAP in a GSK-3β-dependent manner

Yili Jin, Yun Xue, Jiatao Yao, Chengyun Xu, Rui Yu

Journal of Biological Chemistry · 2025-10 · 301 (10) · 110652

DOI: 10.1016/j.jbc.2025.110652 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2025-10. Verfasst von Yili Jin und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Affiliated Dongyang Hospital, Wenzhou Medical University, Dongyang, Zhejiang, China; Department of Biochemistry and Molecular …. Hauptthemen laut MEDLINE: Glycogen Synthase Kinase 3 beta, Ubiquitination, F-Box Proteins, Adaptor Proteins, Signal Transducing. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Jinhua Science and Technology Bureau.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The Hippo signaling pathway effector YAP (Yes-associated protein) serves as a critical transcriptional regulator involved in a wide range of biological processes, including oncogenesis. Despite its potential as a therapeutic target, pharmacologically targeting the Hippo/YAP axis remains challenging, necessitating further exploration of the mechanisms governing YAP regulation. In this study, we identify the Cullin-RING E3 ligase complex SCF-FBXO9-CRL1 as a novel posttranslational regulator of YAP stability. Mechanistically, FBXO9 recognizes YAP through a conserved degron motif and facilitates its K48-linked polyubiquitination at lysine 76 (K76), thereby promoting proteasomal degradation. Notably, we demonstrate that phosphorylation of YAP at Ser338 and Thr342 by GSK-3β primes YAP for FBXO9 recognition, leading to subsequent ubiquitination. Furthermore, our analysis of the signaling cascade reveals that Akt kinase activity modulates this regulatory axis by influencing the phosphorylation status of GSK-3β. Pharmacological inhibition of Akt signaling leads to YAP degradation in a GSK-3β/FBXO9-dependent manner, significantly enhancing chemosensitivity in cancer models. These findings establish a previously unrecognized regulatory axis involving Akt, GSK-3β, FBXO9, and YAP that controls YAP protein turnover, providing a mechanistic basis for therapeutic strategies that combine Akt inhibitors with conventional chemotherapeutics. Our work advances the understanding of posttranslational YAP regulation and identifies several potential therapeutic targets for YAP-driven malignancies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Glycogen Synthase Kinase 3 betaUbiquitinationF-Box ProteinsAdaptor Proteins, Signal TransducingTranscription FactorsProteolysisPhosphoproteinsHumansYAP-Signaling ProteinsPhosphorylationProto-Oncogene Proteins c-aktHEK293 CellsSignal TransductionCell Cycle ProteinsCell Line, TumorAnimals

Stichwörter der Autor:innen

FBXO9GSK-3βHippo signaling pathwayYAPubiquitination

Substanzen

Glycogen Synthase Kinase 3 betaF-Box ProteinsAdaptor Proteins, Signal TransducingTranscription FactorsPhosphoproteinsYAP-Signaling ProteinsYAP1 protein, humanProto-Oncogene Proteins c-aktCell Cycle Proteins

Autor:innen und Institutionen

  • Department of Urology, Affiliated Dongyang Hospital, Wenzhou Medical University, Dongyang, Zhejiang, China; Department of Biochemistry and Molecular Biology, School of Basic Medical Medicine, Health Science Center, Ning…
  • Operating Room, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Department of Biochemistry and Molecular Biology, School of Basic Medical Medicine, Health Science Center, Ningbo University, Ningbo, Zhejiang, China.
  • Department of Urology, Affiliated Dongyang Hospital, Wenzhou Medical University, Dongyang, Zhejiang, China.
  • Department of Biochemistry and Molecular Biology, School of Basic Medical Medicine, Health Science Center, Ningbo University, Ningbo, Zhejiang, China. Electronic address: yurui@nbu.edu.cn.

Förderung

  • Jinhua Science and Technology Bureau

Zitieren

APA

Jin, Y., Xue, Y., Yao, J., Xu, C., & Yu, R. (2025). FBXO9 mediated the ubiquitination and degradation of YAP in a GSK-3β-dependent manner. Journal of Biological Chemistry, 301(10), 110652. https://doi.org/10.1016/j.jbc.2025.110652

Vancouver

Jin Y, Xue Y, Yao J, Xu C, Yu R. FBXO9 mediated the ubiquitination and degradation of YAP in a GSK-3β-dependent manner. Journal of Biological Chemistry. 2025;301(10):110652. doi:10.1016/j.jbc.2025.110652

BibTeX
@article{Jin2025,
  author = {Jin, Yili and Xue, Yun and Yao, Jiatao and Xu, Chengyun and Yu, Rui},
  title = {FBXO9 mediated the ubiquitination and degradation of YAP in a GSK-3β-dependent manner},
  journal = {Journal of Biological Chemistry},
  year = {2025},
  volume = {301},
  number = {10},
  pages = {110652},
  doi = {10.1016/j.jbc.2025.110652}
}
Kostenlos starten →